Betty Pang > Latham & Watkins LLP > San Diego, United States > Lawyer Profile
Latham & Watkins LLP Offices

12670 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
CALIFORNIA
United States
- Firm Profile
- Go to...
Betty Pang

Position
Dr. Betty Pang advises clients in the healthcare and life sciences industry on regulatory matters and corporate transactions.
Betty brings a comprehensive view of the industry to advise clients on complex and sensitive issues pertaining to:
-
- Fraud and abuse
- Self-referral and government program reimbursement compliance
- Facility and provider licensing
- Corporate practice and fee-splitting
She represents a full spectrum of clients in the healthcare ecosystem, including:
-
- Hospitals and health systems
- Physician practice management companies and affiliated practices
- Clinical laboratory and diagnostic service providers
- Telehealth, digital health and wellness companies
- Life science companies, including pharmaceutical, medical device, biotechnology, and medical suppliers
- Private equity firms
- Investment banks
With a seasoned understanding of the industry drawn from prolific deal flow, and a complementary understanding of the scientific and medical issues drawn from her medical degree, she efficiently and effectively support clients through:
-
- Mergers and acquisitions
- Initial public offerings
- Financings
- Joint ventures
- Government investigations
- Day-to-day regulatory and compliance issues
Betty has focused her entire career on the healthcare and life sciences industry, and is a member of the American Health Lawyers Association, the California Society for Healthcare Attorneys, and the American Bar Association Health Law Section. She serves as a Bay Area Local Office Leader for Latham’s Asian and Middle Eastern Lawyers Group and has served as an advisor for the firm’s Diversity Scholars Program.
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Real estate > Land use/zoning
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Environment > Environment: regulatory
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- Environment > Environment: regulatory
- Environment > Environment: regulatory
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Finance > Structured finance: securitization
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > International arbitration
- Intellectual property > Trademarks: litigation
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- M&A/corporate and commercial > Shareholder activism